Rlip-LNA transfection resulted in more robust RALBP1 depletion and more robust transcriptional effects in the breast cancer cells relative to the lung cancer cells; however, this could simply be a function of the faster doubling times of the breast cancer cells, as opposed to biology specific to the cancers of origin. The gene discussed is RALBP1; the disease is lung cancer.